Search

Your search keyword '"Hoekstra, Ronald"' showing total 113 results
Start Over Author "Hoekstra, Ronald"
113 results on '"Hoekstra, Ronald"'

1. Predictive gene expression profile for adjuvant taxane benefit in breast cancer in the MATADOR trial

Author

Linn, Sabine C., Soesan, Marcel, Oosterkamp, Rianne M., Jeurissen, Frank, Weijl, Nir, Imholz, Alex L.T., Portielje, Johanneke E.A., Beelen, Karin J., Bos, Monique E.M.M., van Bochove, Aart, de Klerk, Gerty, Vrijaldenhoven, Suzan, van der Velden, Annette, de Graaf, Hiltje, Smeets, Marielle, Terwogt, Jetske Meerum, Schrama, Jolanda, Kuijer, Philomeen, Wilmink, Hanneke, Hoekstra, Ronald, Kroep, Judith, Pruijt, Hans F.M., van Gerven, Leander, Vos, Allert H., Erdkamp, Frans, van Leeuwen-Breuk, Willemien G., de Graeff, Alexander, Opdam, Mark, van Rossum, Annelot G.J., Hoogstraat, Marlous, Bounova, Gergana, Horlings, Hugo M., van Werkhoven, Erik, Mandjes, Ingrid A.M., van Leeuwen – Stok, A. Elise, Canisius, Sander, van Tinteren, Harm, Bakker, Sandra, Wesseling, Jelle, Kester, Lennart, van Rheenen, Jacco, Rutgers, Emiel J., de Menezes, Renee X., Wessels, Lodewyk F.A., Kok, Marleen, and Oosterkamp, Hendrika M.

Published
2024
Full Text
View/download PDF

2. Results from the UNITED study: a multicenter study validating the prognostic effect of the tumor–stroma ratio in colon cancer

Author

Petrushevska, Gordana, Bogdanovska, Magdalena, Zdravkoski, Panche, Antovic, Svetozar, Dzambaz, Darko, Karagjozov, Panche, de Cuba, Erienne M.V., Beverdam, Frédérique, Jansen, Jan, Vermaas, Maarten, Gašljević, Gorana, Kjær-Frifeldt, Sanne, Lindebjerg, Jan, Strous, Maud, Vogelaar, Jeroen F., Bulkmans, Nicole W.J., van Baarlen, Joop, Mekenkamp, Leonie, Hoekstra, Ronald, Sie, Mark, Cuatrecasas, Miriam, Simonetti, Sara, Rodrigo, María Teresa, Sanz, Iván Archilla, Guerrero Pineda, Jose, Leeuwis-Fedorovich, Natalja E., Talsma, Koen A., Souza da Silva, Ricella M., Lacle, Miangela M., Koopman, Miriam, Dekker, Jan Willem T., van Tilburg, Arjan, Nuciforo, Paolo, Villalobos Alberú, Xenia, Landolfi, Stefania, Zucchiatti, Adriana, Witteveen, Emma, Bordbar, Arad, Hendriks, Mathijs P., Arensman, René, Natu, Shonali, Maka, Noori, Mesker, Wilma E., Tollenaar, Rob A.E.M., Polack, Meaghan, Smit, Marloes A., van Pelt, Gabi W., Putter, Hein, Meershoek-Kleinenbarg, Elma, Roodvoets, Annet G.H., Crobach, Augustinus S.L.P., Gelderblom, Hans, Fontes e Sousa, Mário, Borralho Nunes, Paula, Cruz, João, Raimundo, Ana, Silva, Nelson, Brito, Maria J., Terpstra, Valeska, Zakhartseva, L.M., Al Dieri, Raed, Fléjou, Jean-François, Feakins, Roger, Dequeker, Els, Vink, Geraldine R., van Krieken, J.Han J.M., Polack, M., Smit, M.A., van Pelt, G.W., Roodvoets, A.G.H., Meershoek-Klein Kranenbarg, E., Putter, H., Gelderblom, H., Crobach, A.S.L.P., Terpstra, V., Petrushevska, G., Gašljević, G., Kjær-Frifeldt, S., de Cuba, E.M.V., Bulkmans, N.W.J., Vink, G.R., Al Dieri, R., Tollenaar, R.A.E.M., van Krieken, J.H.J.M., and Mesker, W.E.

Published
2024
Full Text
View/download PDF

3. Association Between Urinary Biomarkers and CKD in Extremely Low Gestational Age Neonates

Author

Thomas, Billy, Elhassan, Nahed, Mulkey, Sarah, Dydynski, Philip, Vijayamadhavan, Vivek K., Mulrooney, Neil, Yoder, Bradley, Kase, Jordan S., Check, Jennifer, Gogcu, Semsa, Osterholm, Erin, Ramel, Sara, Bendel, Catherine, Gale, Cheryl, George, Thomas, Georgieff, Michael, Gisslen, Tate, Guiang, Sixto, III, Hall, Anne, Johnson, Dana, Pfister, Katie, Podgorski, Heather, Roberts, Kari, Stepka, Erin, Engel, Melissa, Kamrath, Heidi, Scheurer, Johannah, Hanson, Angela, Satrom, Katherine, Pfister, Susan, Simones, Ann, Plummer, Erin, Zorn, Elizabeth, Martin, Camilia R., O’Reilly, Deirdre, Porta, Nicolas, Bazacliu, Catalina, Williams, Jonathan, Rajderkar, Dhanashree, Northington, Frances, Valdez, Raul Chavez, Beauman, Sandra, Saurabhkumar, Patel, Diaz-Barbosa, Magaly, Serize, Arturo, Jordan, Jorge, Ott, Debbie, Mora, Ariana Franco, Hedrick, Pamela, Flynn, Vicki, Silvia, Amy, Clopp, Bailey, Feltner, John B., Esposito, Isabella, Hauge, Stephanie, Nikirk, Samantha, Purnell, Andrea, Loy, Emilie, Sikes, Natalie, Mason, Melanie, McConnell, Jana, Brown, Tiffany, Harrison, Henry, Pearson, Denise, Drake, Tammy, Wright, Jocelyn, Walden, Debra, Guy, Annette, Nason, Jennifer, Talbot, Morgan, Lee, Kristen, Penny, Sarah, Boles, Terri, Drummond, Melanie, Kohlleppel, Katy, Kathen, Charmaine, Kaletka, Brian, Gonzales, Shania, Worwa, Cathy, Fisher, Molly, Richter, Tyler, Ginder, Alexander, Reich, Brixen, Rau, Carrie, Loertscher, Manndi, Bledsoe, Laura, McGrath, Kandace, Lewis, Kimberlee Weaver, Burnett, Jill, Schaefer, Susan, Bird, Karie, Giblin, Clare, Daly, Rita, Lanier, Kristi, Warden, Kelly, Wassenaar, Jenna, Ericksen, Jensina, Davern, Bridget, Osborne, Mary Pat, Gregorich, Brittany, Talele, Neha, Obregon, Evelyn, Ziyeh, Tiglath, Clarke, Molly, Wegner, Rachel E., Patel, Palak, Schau, Molly, Russow, Annamarie, Curry, Kelly, Sinnamon, Susan, Barnhart, Lisa, Parkinson, Charlamaine, Hanson, Mary, Kuan, Elizabeth, Lacy, Conra Backstrom, Galvis, Edshelee M., Bombino, Susana, Martinez, Denise, Bell, Suzi, Long, Corrie, Longa, Cathy, Westerveld, Michael, McConkey, Stacy, Hay, Anne, Natarajan, Niranjana, Gaudette, Shari, Cobb, Sarah, Sharp, Gregory, Schumacher, Elizabeth, Schuschke, Leslie, Frey, Charlotte, Fierro, Mario, Gilmore, Lois, Lundequam, Pamela, Hoekstra, Ronald, Ketko, Anastasia, Perdue, Nina, Cunningham, Sean, Stout, Kelly, Hall, Becky, Morshedzadeh, Galina, Ostrander, Betsy, Winter, Sarah, Cox, Lauren, Rainaldi, Matthew A., Hensley, Sarah, Morris, Melissa, Roberts, Dia, Tuttle, Melissa, Boys, Christopher, Hultgren, Solveig, Pierpont, Elizabeth I., Fahim, Nancy, George, Tom, King, Kelly E., Bataglia, Katherine, Neis, Cathy, Bergeron, Mark, Miller, Cristina, Accomando, Cara, Gavin, Jennifer Anne, Maczek, Elizabeth, Marakovitz, Susan, Knorr, Aimee, Smith, Vincent C., Stewart, Jane E., Weissbourd, Marie, deRegnier, Raye-Ann, Matoba, Nana, Heaton, Shelly C., Cascio, Erika M., Brady, Janet, Ghosh, Suman, Ditto, Jessica, Leppert, Mary, Lowe, Jean, Fuller, Janell, DuPont, Tara, Ohls, Robin, Kloska, Pamela, Patel, Saurabh, Carbonell, Lauren, Patino-Fernandez, Anna Maria, de Lerma, Carmen, McDonough, Kelly, De Cortada, Maiana, Chavis, Lacy, Shannon, Jane, Hingorani, Sangeeta R., Schmicker, Robert H., Halloran, Brian, Brophy, Patrick, Heagerty, Patrick J., Juul, Sandra, Goldstein, Stuart L., and Askenazi, David

Published
2024
Full Text
View/download PDF

4. First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer Group

Author

Van Gulik, Thomas, Huiskens, Joost, Van Tinteren, Harm, Dejong, Cornelis H.C., Grünhagen, Dirk J., Patijn, Gijs A., Ruers, Theo J.M., Chapelle, Thiery, Hermans, John J., Leclercq, Wouter K.G., Valkenburg-van Iersel, Liselot B.J., Grootscholten, Cecile, Van Dodewaard-de Jong, Joyce M., Vincent, Jeroen, Houtsma, Danny, Los, Maartje, Den Boer, Marien, Trajkovic-Vidakovic, Marija, Van Voorthuizen, Theo, Koopman, Miriam, Vestjens, Johanneke H.M.J.V., Torrenga, Hans, Mekenkamp, Leonie J., Veldhuis, Gerrit Jan, Polee, Marco B., Dohmen, Serge E., Schut, Heidi, Vulink, Annelie J.E., Van Halteren, Henk K., Oulad Hadj, Jamal, Schiphorst, Pieter-Paul J.B.M., Hoekstra, Ronald, Bond, Marinde J G, Bolhuis, Karen, Loosveld, Olaf J L, de Groot, Jan Willem B, Droogendijk, Helga, Helgason, Helgi H, Hendriks, Mathijs P, Klaase, Joost M, Kazemier, Geert, Liem, Mike S L, Rijken, Arjen M, Verhoef, Cornelis, de Wilt, Johannes H W, de Jong, Koert P, Gerhards, Michael F, van Amerongen, Martinus J, Engelbrecht, Marc R W, van Lienden, Krijn P, Molenaar, I Quintus, de Valk, Bart, Haberkorn, Brigitte C M, Kerver, Emile D, Erdkamp, Frans, van Alphen, Robbert J, Mathijssen-van Stein, Daniëlle, Komurcu, Aysun, Lopez-Yurda, Marta, Swijnenburg, Rutger-Jan, and Punt, Cornelis J A

Published
2023
Full Text
View/download PDF

5. Quality of Life and Survival of Metastatic Colorectal Cancer Patients Treated With Trifluridine-Tipiracil (QUALITAS)

Author

Beerepoot, Laurens V., Creemers, Geert-Jan, van Cruijsen, Hester, de Groot, Jan Willem B., van Halteren, Henk K., Helgason, Helgi H., Hendriks, Mathijs P., Hoekstra, Ronald, van Huis-Tanja, Lieke H., Kapiteijn, Ellen, Los, Maartje, van Meerten, Esther, Peters, Natascha A.J.B., Pruijt, Johannes F.M., van Ufford-Mannesse, Patricia Quarles, Sie, Mark P.S., Sommeijer, Dirkje W., Spierings, Leontine E.A.M.M., Terheggen, Frederiek, Tjin-A-Ton, Manuel L.R., Valkenburg-van Iersel, Liselot B.J., van Voorthuizen, Theo, de Vos-Geelen, Judith, Vulink, Annelie J.E., J van de Wouw, Agnès, Hamers, Patricia A.H., Vink, Geraldine R., Elferink, Marloes A.G., Stellato, Rebecca K., Dijksterhuis, Willemieke P.M., Punt, Cornelis J.A., Koopman, Miriam, and May, Anne M.

Published
2022
Full Text
View/download PDF

6. Fecal, duodenal, and tumor microbiota composition of esophageal carcinoma patients, a longitudinal prospective cohort.

Author

van den Ende, Tom, Clercq, Nicolien C de, Davids, Mark, Goedegebuure, Ruben, Doeve, Benthe H, Ebrahimi, Gati, Buijsen, Jeroen, Hoekstra, Ronald, Mohammad, Nadia Haj, Bijlsma, Maarten F, Nieuwdorp, Max, and Laarhoven, Hanneke W M van

Subjects
IMMUNE checkpoint inhibitors, NEOADJUVANT chemotherapy, IMMUNE checkpoint proteins, RIBOSOMAL RNA, PROGRESSION-free survival, CHEMORADIOTHERAPY, DUODENAL tumors
Abstract

Background The microbiome has been associated with chemotherapy and immune checkpoint inhibitor efficacy. How this pertains to resectable esophageal carcinoma is unknown. Our aim was to identify microbial signatures in resectable esophageal carcinoma associated with response to neoadjuvant chemoradiotherapy with or without an immune checkpoint inhibitor. Methods From 2 prospectively collected esophageal carcinoma cohorts (n = 172 in total) treated with neoadjuvant chemoradiotherapy alone (n = 132) or a combination of neoadjuvant chemoradiotherapy and an immune checkpoint inhibitor (n = 40), fecal samples were available at baseline, during treatment, and presurgery. Additionally, in the immune checkpoint inhibitor–treated patients, tumor and duodenal snap frozen biopsies were collected over time. Fecal, tumor, and duodenal DNA were extracted for 16S ribosomal RNA sequencing. Associations were investigated between microbiome composition pathological complete response and progression-free survival (PFS). Results There was a statistically significant shift in the microbiota profile of the fecal, tumor, and duodenal microbiota over time. In the total cohort, patients with a pathological complete response had a stable fecal alpha diversity, while the diversity of poor responders decreased during treatment (P  = .036). Presurgery, lower alpha diversity (<4.12) was related to worse PFS (log-rank P  = .025). Baseline tumor biopsies of patients with short PFS had more Fusobacterium. A low baseline duodenal alpha diversity (<3.96) was associated with worse PFS (log-rank P  = .012). Conclusions Lower intestinal alpha diversity was associated with worse response and survival of esophageal carcinoma patients. In tumor biopsies, Fusobacterium was more abundant in patients with poor PFS. After further mechanistic validation, these findings may aid in response prediction and the design of novel microbiome modulating treatments for esophageal carcinoma patients. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

7. Association Between Urinary Biomarkers and CKD in Extremely Low Gestational Age Neonates

Author

Hingorani, Sangeeta R., primary, Schmicker, Robert H., additional, Halloran, Brian, additional, Brophy, Patrick, additional, Heagerty, Patrick J., additional, Juul, Sandra, additional, Goldstein, Stuart L., additional, Askenazi, David, additional, Thomas, Billy, additional, Elhassan, Nahed, additional, Mulkey, Sarah, additional, Dydynski, Philip, additional, Vijayamadhavan, Vivek K., additional, Mulrooney, Neil, additional, Yoder, Bradley, additional, Kase, Jordan S., additional, Check, Jennifer, additional, Gogcu, Semsa, additional, Osterholm, Erin, additional, Ramel, Sara, additional, Bendel, Catherine, additional, Gale, Cheryl, additional, George, Thomas, additional, Georgieff, Michael, additional, Gisslen, Tate, additional, Guiang, Sixto, additional, Hall, Anne, additional, Johnson, Dana, additional, Pfister, Katie, additional, Podgorski, Heather, additional, Roberts, Kari, additional, Stepka, Erin, additional, Engel, Melissa, additional, Kamrath, Heidi, additional, Scheurer, Johannah, additional, Hanson, Angela, additional, Satrom, Katherine, additional, Pfister, Susan, additional, Simones, Ann, additional, Plummer, Erin, additional, Zorn, Elizabeth, additional, Martin, Camilia R., additional, O’Reilly, Deirdre, additional, Porta, Nicolas, additional, Bazacliu, Catalina, additional, Williams, Jonathan, additional, Rajderkar, Dhanashree, additional, Northington, Frances, additional, Valdez, Raul Chavez, additional, Beauman, Sandra, additional, Saurabhkumar, Patel, additional, Diaz-Barbosa, Magaly, additional, Serize, Arturo, additional, Jordan, Jorge, additional, Ott, Debbie, additional, Mora, Ariana Franco, additional, Hedrick, Pamela, additional, Flynn, Vicki, additional, Silvia, Amy, additional, Clopp, Bailey, additional, Feltner, John B., additional, Esposito, Isabella, additional, Hauge, Stephanie, additional, Nikirk, Samantha, additional, Purnell, Andrea, additional, Loy, Emilie, additional, Sikes, Natalie, additional, Mason, Melanie, additional, McConnell, Jana, additional, Brown, Tiffany, additional, Harrison, Henry, additional, Pearson, Denise, additional, Drake, Tammy, additional, Wright, Jocelyn, additional, Walden, Debra, additional, Guy, Annette, additional, Nason, Jennifer, additional, Talbot, Morgan, additional, Lee, Kristen, additional, Penny, Sarah, additional, Boles, Terri, additional, Drummond, Melanie, additional, Kohlleppel, Katy, additional, Kathen, Charmaine, additional, Kaletka, Brian, additional, Gonzales, Shania, additional, Worwa, Cathy, additional, Fisher, Molly, additional, Richter, Tyler, additional, Ginder, Alexander, additional, Reich, Brixen, additional, Rau, Carrie, additional, Loertscher, Manndi, additional, Bledsoe, Laura, additional, McGrath, Kandace, additional, Lewis, Kimberlee Weaver, additional, Burnett, Jill, additional, Schaefer, Susan, additional, Bird, Karie, additional, Giblin, Clare, additional, Daly, Rita, additional, Lanier, Kristi, additional, Warden, Kelly, additional, Wassenaar, Jenna, additional, Ericksen, Jensina, additional, Davern, Bridget, additional, Osborne, Mary Pat, additional, Gregorich, Brittany, additional, Talele, Neha, additional, Obregon, Evelyn, additional, Ziyeh, Tiglath, additional, Clarke, Molly, additional, Wegner, Rachel E., additional, Patel, Palak, additional, Schau, Molly, additional, Russow, Annamarie, additional, Curry, Kelly, additional, Sinnamon, Susan, additional, Barnhart, Lisa, additional, Parkinson, Charlamaine, additional, Hanson, Mary, additional, Kuan, Elizabeth, additional, Lacy, Conra Backstrom, additional, Galvis, Edshelee M., additional, Bombino, Susana, additional, Martinez, Denise, additional, Bell, Suzi, additional, Long, Corrie, additional, Longa, Cathy, additional, Westerveld, Michael, additional, McConkey, Stacy, additional, Hay, Anne, additional, Natarajan, Niranjana, additional, Gaudette, Shari, additional, Cobb, Sarah, additional, Sharp, Gregory, additional, Schumacher, Elizabeth, additional, Schuschke, Leslie, additional, Frey, Charlotte, additional, Fierro, Mario, additional, Gilmore, Lois, additional, Lundequam, Pamela, additional, Hoekstra, Ronald, additional, Ketko, Anastasia, additional, Perdue, Nina, additional, Cunningham, Sean, additional, Stout, Kelly, additional, Hall, Becky, additional, Morshedzadeh, Galina, additional, Ostrander, Betsy, additional, Winter, Sarah, additional, Cox, Lauren, additional, Rainaldi, Matthew A., additional, Hensley, Sarah, additional, Morris, Melissa, additional, Roberts, Dia, additional, Tuttle, Melissa, additional, Boys, Christopher, additional, Hultgren, Solveig, additional, Pierpont, Elizabeth I., additional, Fahim, Nancy, additional, George, Tom, additional, King, Kelly E., additional, Bataglia, Katherine, additional, Neis, Cathy, additional, Bergeron, Mark, additional, Miller, Cristina, additional, Accomando, Cara, additional, Gavin, Jennifer Anne, additional, Maczek, Elizabeth, additional, Marakovitz, Susan, additional, Knorr, Aimee, additional, Smith, Vincent C., additional, Stewart, Jane E., additional, Weissbourd, Marie, additional, deRegnier, Raye-Ann, additional, Matoba, Nana, additional, Heaton, Shelly C., additional, Cascio, Erika M., additional, Brady, Janet, additional, Ghosh, Suman, additional, Ditto, Jessica, additional, Leppert, Mary, additional, Lowe, Jean, additional, Fuller, Janell, additional, DuPont, Tara, additional, Ohls, Robin, additional, Kloska, Pamela, additional, Patel, Saurabh, additional, Carbonell, Lauren, additional, Patino-Fernandez, Anna Maria, additional, de Lerma, Carmen, additional, McDonough, Kelly, additional, De Cortada, Maiana, additional, Chavis, Lacy, additional, and Shannon, Jane, additional

Published
2024
Full Text
View/download PDF

8. Results from the UNITED study: a multicenter study validating the prognostic effect of the tumor–stroma ratio in colon cancer

Author

Polack, M., primary, Smit, M.A., additional, van Pelt, G.W., additional, Roodvoets, A.G.H., additional, Meershoek-Klein Kranenbarg, E., additional, Putter, H., additional, Gelderblom, H., additional, Crobach, A.S.L.P., additional, Terpstra, V., additional, Petrushevska, G., additional, Gašljević, G., additional, Kjær-Frifeldt, S., additional, de Cuba, E.M.V., additional, Bulkmans, N.W.J., additional, Vink, G.R., additional, Al Dieri, R., additional, Tollenaar, R.A.E.M., additional, van Krieken, J.H.J.M., additional, Mesker, W.E., additional, Petrushevska, Gordana, additional, Bogdanovska, Magdalena, additional, Zdravkoski, Panche, additional, Antovic, Svetozar, additional, Dzambaz, Darko, additional, Karagjozov, Panche, additional, de Cuba, Erienne M.V., additional, Beverdam, Frédérique, additional, Jansen, Jan, additional, Vermaas, Maarten, additional, Gašljević, Gorana, additional, Kjær-Frifeldt, Sanne, additional, Lindebjerg, Jan, additional, Strous, Maud, additional, Vogelaar, Jeroen F., additional, Bulkmans, Nicole W.J., additional, van Baarlen, Joop, additional, Mekenkamp, Leonie, additional, Hoekstra, Ronald, additional, Sie, Mark, additional, Cuatrecasas, Miriam, additional, Simonetti, Sara, additional, Rodrigo, María Teresa, additional, Sanz, Iván Archilla, additional, Guerrero Pineda, Jose, additional, Leeuwis-Fedorovich, Natalja E., additional, Talsma, Koen A., additional, Souza da Silva, Ricella M., additional, Lacle, Miangela M., additional, Koopman, Miriam, additional, Dekker, Jan Willem T., additional, van Tilburg, Arjan, additional, Nuciforo, Paolo, additional, Villalobos Alberú, Xenia, additional, Landolfi, Stefania, additional, Zucchiatti, Adriana, additional, Witteveen, Emma, additional, Bordbar, Arad, additional, Hendriks, Mathijs P., additional, Arensman, René, additional, Natu, Shonali, additional, Maka, Noori, additional, Mesker, Wilma E., additional, Tollenaar, Rob A.E.M., additional, Polack, Meaghan, additional, Smit, Marloes A., additional, van Pelt, Gabi W., additional, Putter, Hein, additional, Meershoek-Kleinenbarg, Elma, additional, Roodvoets, Annet G.H., additional, Crobach, Augustinus S.L.P., additional, Gelderblom, Hans, additional, Fontes e Sousa, Mário, additional, Borralho Nunes, Paula, additional, Cruz, João, additional, Raimundo, Ana, additional, Silva, Nelson, additional, Brito, Maria J., additional, Terpstra, Valeska, additional, Zakhartseva, L.M., additional, Al Dieri, Raed, additional, Fléjou, Jean-François, additional, Feakins, Roger, additional, Dequeker, Els, additional, Vink, Geraldine R., additional, and van Krieken, J.Han J.M., additional

Published
2024
Full Text
View/download PDF

9. The Impact of Erythropoietin on Short- and Long-Term Kidney-Related Outcomes in Neonates of Extremely Low Gestational Age. Results of a Multicenter, Double-Blind, Placebo-Controlled Randomized Clinical Trial

Author

Juul, Sandra E., Comstock, Bryan A., Wadhawan, Rajan, Mayock, Dennis E., Courtney, Sherry E., Robinson, Tonya, Ahmad, Kaashif A., Bendel-Stenzel, Ellen, Baserga, Mariana, LaGamma, Edmund F., Downey, L. Corbin, Rao, Raghavendra, Fahim, Nancy, Lampland, Andrea, Frantz, Ivan D., III, Khan, Janine Y., Weiss, Michael, Gilmore, Maureen M., Ohls, Robin, Srinivasan, Nishant, Perez, Jorge E., McKay, Victor, Vu, Phuong T., Heagerty, Patrick J., Thomas, Billy, Elhassan, Nahed, Mulkey, Sarah, Dydynski, Philip, Vijayamadhavan, Vivek K., Mulrooney, Neil, Yoder, Bradley, Kase, Jordan S., Check, Jennifer, Gogcu, Semsa, Osterholm, Erin, Ramel, Sara, Bendel, Catherine, Gale, Cheryl, George, Thomas, Georgieff, Michael, Gisslen, Tate, Guiang, Sixto, III, Hall, Anne, Johnson, Dana, Pfister, Katie, Podgorski, Heather, Roberts, Kari, Stepka, Erin, Engel, Melissa, Kamrath, Heidi, Scheurer, Johannah, Hanson, Angela, Satrom, Katherine, Pfister, Susan, Simones, Ann, Plummer, Erin, Zorn, Elizabeth, Martin, Camilia R., O'Reilly, Deirdre, Porta, Nicolas, Bazacliu, Catalina, Williams, Jonathan, Rajderkar, Dhanashree, Northington, Frances, Valdez, Raul Chavez, Beauman, Sandra, Saurabhkumar, Patel, Diaz-Barbosa, Magaly, Serize, Arturo, Jordan, Jorge, Ott, Debbie, Mora, Ariana Franco, Hedrick, Pamela, Flynn, Vicki, Silvia, Amy, Clopp, Bailey, Feltner, John B., Esposito, Isabella, Hauge, Stephanie, Nikirk, Samantha, Purnell, Andrea, Loy, Emilie, Sikes, Natalie, Mason, Melanie, McConnell, Jana, Brown, Tiffany, Harrison, Henry, Pearson, Denise, Drake, Tammy, Wright, Jocelyn, Walden, Debra, Guy, Annette, Nason, Jennifer, Talbot, Morgan, Lee, Kristen, Penny, Sarah, Boles, Terri, Drummond, Melanie, Kohlleppel, Katy, Kathen, Charmaine, Kaletka, Brian, Gonzales, Shania, Worwa, Cathy, Fisher, Molly, Richter, Tyler, Ginder, Alexander, Reich, Brixen, Rau, Carrie, Loertscher, Manndi, Bledsoe, Laura, McGrath, Kandace, Lewis, Kimberlee Weaver, Burnett, Jill, Schaefer, Susan, Bird, Karie, Giblin, Clare, Daly, Rita, Lanier, Kristi, Warden, Kelly, Wassenaar, Jenna, Ericksen, Jensina, Davern, Bridget, Osborne, Mary Pat, Gregorich, Brittany, Talele, Neha, Obregon, Evelyn, Ziyeh, Tiglath, Clarke, Molly, Wegner, Rachel E., Patel, Palak, Schau, Molly, Russow, Annamarie, Curry, Kelly, Sinnamon, Susan, Barnhart, Lisa, Parkinson, Charlamaine, Hanson, Mary, Kuan, Elizabeth, Lacy, Conra Backstrom, Galvis, Edshelee M., Bombino, Susana, Martinez, Denise, Bell, Suzi, Long, Corrie, Longa, Cathy, Westerveld, Michael, McConkey, Stacy, Hay, Anne, Natarajan, Niranjana, Gaudette, Shari, Cobb, Sarah, Sharp, Gregory, Schumacher, Elizabeth, Schuschke, Leslie, Frey, Charlotte, Fierro, Mario, Gilmore, Lois, Lundequam, Pamela, Hoekstra, Ronald, Ketko, Anastasia, Perdue, Nina, Cunningham, Sean, Stout, Kelly, Hall, Becky, Morshedzadeh, Galina, Ostrander, Betsy, Winter, Sarah, Cox, Lauren, Rainaldi, Matthew A., Hensley, Sarah, Morris, Melissa, Roberts, Dia, Tuttle, Melissa, Boys, Christopher, Hultgren, Solveig, Pierpont, Elizabeth I., George, Tom, King, Kelly E., Bataglia, Katherine, Neis, Cathy, Bergeron, Mark, Miller, Cristina, Accomando, Cara, Gavin, Jennifer Anne, Maczek, Elizabeth, Marakovitz, Susan, Knorr, Aimee, Smith, Vincent C., Stewart, Jane E., Weissbourd, Marie, deRegnier, Raye-Ann, Matoba, Nana, Heaton, Shelly C., Cascio, Erika M., Brady, Janet, Ghosh, Suman, Ditto, Jessica, Leppert, Mary, Lowe, Jean, Fuller, Janell, DuPont, Tara, Kloska, Pamela, Patel, Saurabh, Carbonell, Lauren, Patino-Fernandez, Anna Maria, de Lerma, Carmen, McDonough, Kelly, De Cortada, Maiana, Chavis, Lacy, Shannon, Jane, Konodi, Mark A., Nefcy, Christopher, Kuban, Karl C.K., Lowe, Jean R., O'Shea, T. Michael, Dighe, Manjiri, Richards, Todd, Shaw, Dennis W.W., Studholme, Colin, Traudt, Christopher M., Ballard, Roberta, Hartman, Adam, Janis, Scott, Ohls, T. Robin, O'Shea, Michael, Guillet, Ronnie, Ball, M. Bethany, Glass, Hannah, Saville, Ben, Schreiber, Michael, Askenazi, David J., Schmicker, Robert H., Brophy, Patrick, Goldstein, Stuart L., and Hingorani, Sangeeta

Published
2021
Full Text
View/download PDF

10. Determinants of Physical Activity among Patients with Colorectal Cancer: From Diagnosis to 5 Years after Diagnosis

Author

Epi Kanker Team B, Cancer, Biostatistiek Onderwijs, Apotheek Bereidingen, Anatomie, MS CGO, MS Hematologie, MS Medische Oncologie, Epi Kanker, JC onderzoeksprogramma Cancer, Smit, Karel C, Derksen, Jeroen W G, Stellato, Rebecca K, van Lanen, Anne-Sophie, Wesselink, Evertine, Belt, Eric J Th, Cloos-van Balen, Marissa, Coene, Peter Paul L O, Dekker, Jan Willem T, de Groot, Jan Willem, Haringhuizen, Annebeth W, van Halteren, Henk K, van Heek, Tjarda T, Helgason, Helgi H, Hendriks, Mathijs P, de Hingh, Ignace H J T, Hoekstra, Ronald, Houtsma, Danny, Janssen, Johan J B, Kok, Niels, Konsten, Joop L M, Los, Maartje, Meijerink, Martijn R, Mekenkamp, Leonie J M, Peeters, Koen C M J, Polée, Marco B, Rietbroek, Ron C, Schiphorst, Anandi H W, Schrauwen, Ruud W M, Schreinemakers, Jennifer, Sie, Mark P S, Simkens, Lieke, Sonneveld, Eric J A, Terheggen, Frederiek, Valkenburg-van Iersel, Liselot, Vles, Wouter J, Wasowicz-Kemps, Daria K, de Wilt, Johannes H W, Kok, Dieuwertje E, Winkels, Renate M, Kampman, Ellen, van Duijnhoven, Fränzel J B, Koopman, Miriam, May, Anne M, Epi Kanker Team B, Cancer, Biostatistiek Onderwijs, Apotheek Bereidingen, Anatomie, MS CGO, MS Hematologie, MS Medische Oncologie, Epi Kanker, JC onderzoeksprogramma Cancer, Smit, Karel C, Derksen, Jeroen W G, Stellato, Rebecca K, van Lanen, Anne-Sophie, Wesselink, Evertine, Belt, Eric J Th, Cloos-van Balen, Marissa, Coene, Peter Paul L O, Dekker, Jan Willem T, de Groot, Jan Willem, Haringhuizen, Annebeth W, van Halteren, Henk K, van Heek, Tjarda T, Helgason, Helgi H, Hendriks, Mathijs P, de Hingh, Ignace H J T, Hoekstra, Ronald, Houtsma, Danny, Janssen, Johan J B, Kok, Niels, Konsten, Joop L M, Los, Maartje, Meijerink, Martijn R, Mekenkamp, Leonie J M, Peeters, Koen C M J, Polée, Marco B, Rietbroek, Ron C, Schiphorst, Anandi H W, Schrauwen, Ruud W M, Schreinemakers, Jennifer, Sie, Mark P S, Simkens, Lieke, Sonneveld, Eric J A, Terheggen, Frederiek, Valkenburg-van Iersel, Liselot, Vles, Wouter J, Wasowicz-Kemps, Daria K, de Wilt, Johannes H W, Kok, Dieuwertje E, Winkels, Renate M, Kampman, Ellen, van Duijnhoven, Fränzel J B, Koopman, Miriam, and May, Anne M

Published
2024

11. Chemotherapy-Induced Peripheral Neuropathy in Patients With Gastroesophageal Cancer

Author

MS Medische Oncologie, Cancer, van Velzen, Merel J M, Pape, Marieke, Sprangers, Mirjam A G, van Kleef, Jessy Joy, Mostert, Bianca, Beerepoot, Laurens V, Slingerland, Marije, Gootjes, Elske C, Hoekstra, Ronald, van de Poll-Franse, Lonneke V, Haj Mohammad, Nadia, van Laarhoven, Hanneke W M, MS Medische Oncologie, Cancer, van Velzen, Merel J M, Pape, Marieke, Sprangers, Mirjam A G, van Kleef, Jessy Joy, Mostert, Bianca, Beerepoot, Laurens V, Slingerland, Marije, Gootjes, Elske C, Hoekstra, Ronald, van de Poll-Franse, Lonneke V, Haj Mohammad, Nadia, and van Laarhoven, Hanneke W M

Published
2024

12. Determinants of Physical Activity among Patients with Colorectal Cancer: From Diagnosis to Five Years after Diagnosis

Author

Smit, Karel C., Derksen, Jeroen W.G., Stellato, Rebecca K., van Lanen, Anne-Sophie, Wesselink, Evertine, Belt, Eric J.T., Cloos-van Balen, Marissa, Coene, Peter Paul L.O., Dekker, Jan Willem T., de Groot, Jan Willem, Haringhuizen, Annebeth W., van Halteren, Henk K., van Heek, Tjarda T., Helgason, Helgi H., Hendriks, Mathijs P., de Hingh, Ignace H.J.T., Hoekstra, Ronald, Houtsma, Danny, Janssen, Johan J.B., Kok, Niels, Konsten, Joop L.M., Los, Maartje, Meijerink, Martijn R., Mekenkamp, Leonie J.M., Peeters, Koen C.M.J., Polée, Marco B., Rietbroek, Ron C., Schiphorst, Anandi H.W., Schrauwen, Ruud W.M., Schreinemakers, Jennifer, Sie, Mark P.S., Simkens, Lieke, Sonneveld, Eric J.A., Terheggen, Frederiek, Valkenburg-van Iersel, Liselot, Vles, Wouter J., Wasowicz-Kemps, Daria K., de Wilt, Johannes H.W., Kok, Dieuwertje E., Winkels, Renate M., Kampman, Ellen, van Duijnhoven, Fränzel J.B., Koopman, Miriam, May, Anne M., Smit, Karel C., Derksen, Jeroen W.G., Stellato, Rebecca K., van Lanen, Anne-Sophie, Wesselink, Evertine, Belt, Eric J.T., Cloos-van Balen, Marissa, Coene, Peter Paul L.O., Dekker, Jan Willem T., de Groot, Jan Willem, Haringhuizen, Annebeth W., van Halteren, Henk K., van Heek, Tjarda T., Helgason, Helgi H., Hendriks, Mathijs P., de Hingh, Ignace H.J.T., Hoekstra, Ronald, Houtsma, Danny, Janssen, Johan J.B., Kok, Niels, Konsten, Joop L.M., Los, Maartje, Meijerink, Martijn R., Mekenkamp, Leonie J.M., Peeters, Koen C.M.J., Polée, Marco B., Rietbroek, Ron C., Schiphorst, Anandi H.W., Schrauwen, Ruud W.M., Schreinemakers, Jennifer, Sie, Mark P.S., Simkens, Lieke, Sonneveld, Eric J.A., Terheggen, Frederiek, Valkenburg-van Iersel, Liselot, Vles, Wouter J., Wasowicz-Kemps, Daria K., de Wilt, Johannes H.W., Kok, Dieuwertje E., Winkels, Renate M., Kampman, Ellen, van Duijnhoven, Fränzel J.B., Koopman, Miriam, and May, Anne M.

Abstract

Introduction: Physical activity (PA) is associated with higher quality of life and probably better prognosis among colorectal cancer (CRC) patients. This study focuses on determinants of PA among CRC patients from diagnosis until five years post-diagnosis.Methods: Sociodemographic and disease-related factors of participants of two large CRC cohort studies were combined. Moderate-to-vigorous PA during sport and leisure time (MVPA-SL) was measured at diagnosis (T0) and six, twelve, twenty-four, and sixty (T6 to T60) months post-diagnosis, using the SQUASH questionnaire. Mixed-effects models were performed to identify sociodemographic and disease-related determinants of MVPA-SL, separately for stage I-III colon (CC), stage I-III rectal cancer (RC), and stage IV CRC (T0 and T6 only). Associations were defined as consistently present when significant at ≥4 timepoints for the stage I-III subsets. MVPA-SL levels were compared with an age- and sex-matched sample of the general Dutch population.Results: In total, 2905 CC, 1459 RC and 436 stage IV CRC patients were included. Patients with higher fatigue scores, and women compared to men had consistently lower MVPA-SL levels over time, regardless of tumor type and stage. At T6, having a stoma was significantly associated with lower MVPA-SL among stage I-III RC patients. Systemic therapy and radiotherapy were not significantly associated with MVPA-SL changes at T6. Compared to the general population, MVPA-SL levels of CRC patients were lower at all timepoints, most notably at T6.Conclusions: Female sex and higher fatigue scores were consistent determinants of lower MVPA-SL levels among all CRC patients, and MVPA-SL levels were lowest at six months post-diagnosis. Our results can inform the design of intervention studies aimed at improving PA, and guide healthcare professionals in optimizing individualized support.

Published
2024

13. Determinants of Physical Activity among Patients with Colorectal Cancer: From Diagnosis to Five Years after Diagnosis

Author

Smit, Karel C., primary, Derksen, Jeroen W.G., additional, Stellato, Rebecca K., additional, van Lanen, Anne-Sophie, additional, Wesselink, Evertine, additional, Belt, Eric J. Th., additional, Cloos-van Balen, Marissa, additional, Coene, Peter Paul L.O., additional, Dekker, Jan Willem T., additional, de Groot, Jan Willem, additional, Haringhuizen, Annebeth W., additional, van Halteren, Henk K., additional, van Heek, Tjarda T., additional, Helgason, Helgi H., additional, Hendriks, Mathijs P., additional, de Hingh, Ignace H.J.T., additional, Hoekstra, Ronald, additional, Houtsma, Danny, additional, Janssen, Johan J.B., additional, Kok, Niels, additional, Konsten, Joop L.M., additional, Los, Maartje, additional, Meijerink, Martijn R., additional, Mekenkamp, Leonie J.M., additional, Peeters, Koen C.M.J., additional, Polée, Marco B., additional, Rietbroek, Ron C., additional, Schiphorst, Anandi H.W., additional, Schrauwen, Ruud W.M., additional, Schreinemakers, Jennifer, additional, Sie, Mark P.S., additional, Simkens, Lieke, additional, Sonneveld, Eric J.A., additional, Terheggen, Frederiek, additional, Valkenburg-van Iersel, Liselot, additional, Vles, Wouter J., additional, Wasowicz-Kemps, Daria K., additional, de Wilt, Johannes H.W., additional, Kok, Dieuwertje E., additional, Winkels, Renate M., additional, Kampman, Ellen, additional, van Duijnhoven, Fränzel J.B., additional, Koopman, Miriam, additional, and May, Anne M., additional

Published
2023
Full Text
View/download PDF

14. First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer Group

Author

Bond, Marinde J G, primary, Bolhuis, Karen, additional, Loosveld, Olaf J L, additional, de Groot, Jan Willem B, additional, Droogendijk, Helga, additional, Helgason, Helgi H, additional, Hendriks, Mathijs P, additional, Klaase, Joost M, additional, Kazemier, Geert, additional, Liem, Mike S L, additional, Rijken, Arjen M, additional, Verhoef, Cornelis, additional, de Wilt, Johannes H W, additional, de Jong, Koert P, additional, Gerhards, Michael F, additional, van Amerongen, Martinus J, additional, Engelbrecht, Marc R W, additional, van Lienden, Krijn P, additional, Molenaar, I Quintus, additional, de Valk, Bart, additional, Haberkorn, Brigitte C M, additional, Kerver, Emile D, additional, Erdkamp, Frans, additional, van Alphen, Robbert J, additional, Mathijssen-van Stein, Daniëlle, additional, Komurcu, Aysun, additional, Lopez-Yurda, Marta, additional, Swijnenburg, Rutger-Jan, additional, Punt, Cornelis J A, additional, Van Gulik, Thomas, additional, Huiskens, Joost, additional, Van Tinteren, Harm, additional, Dejong, Cornelis H.C., additional, Grünhagen, Dirk J., additional, Patijn, Gijs A., additional, Ruers, Theo J.M., additional, Chapelle, Thiery, additional, Hermans, John J., additional, Leclercq, Wouter K.G., additional, Valkenburg-van Iersel, Liselot B.J., additional, Grootscholten, Cecile, additional, Van Dodewaard-de Jong, Joyce M., additional, Vincent, Jeroen, additional, Houtsma, Danny, additional, Los, Maartje, additional, Den Boer, Marien, additional, Trajkovic-Vidakovic, Marija, additional, Van Voorthuizen, Theo, additional, Koopman, Miriam, additional, Vestjens, Johanneke H.M.J.V., additional, Torrenga, Hans, additional, Mekenkamp, Leonie J., additional, Veldhuis, Gerrit Jan, additional, Polee, Marco B., additional, Dohmen, Serge E., additional, Schut, Heidi, additional, Vulink, Annelie J.E., additional, Van Halteren, Henk K., additional, Oulad Hadj, Jamal, additional, Schiphorst, Pieter-Paul J.B.M., additional, and Hoekstra, Ronald, additional

Published
2023
Full Text
View/download PDF

15. Physical Activity Is Associated with Improved Overall Survival among Patients with Metastatic Colorectal Cancer

Author

Smit, Karel C., Derksen, Jeroen W.G., Beets, Geerard L.O., Belt, Eric J.Th, Berbée, Maaike, Coene, Peter Paul L.O., Van Cruijsen, Hester, Davidis, Marjan A., Dekker, Jan Willem T., Van Dodewaard-De Jong, Joyce M., Haringhuizen, Annebeth W., Helgason, Helgi H., Hendriks, Mathijs P., Hoekstra, Ronald, De Hingh, Ignace H.J.T., Ijzermans, Jan N.M., Janssen, Johan J.B., Konsten, Joop L.M., Los, Maartje, Mekenkamp, Leonie J.M., Nieboer, Peter, Peeters, Koen C.M.J., Peters, Natascha A.J.B., Pruijt, Hans J.F.M., Van Ufford-Mannesse, Patricia Quarles, Rietbroek, Ron C., Schiphorst, Anandi H.W., Van Der Velden, Arjan Schouten, Schrauwen, Ruud W.M., Sie, Mark P.S., Sommeijer, Dirkje W., Sonneveld, Dirk J.A., Stockmann, Hein B.A.C., Tent, Marleen, Terheggen, Frederiek, Tjin-A-Ton, Manuel L.R., Valkenburg-Van Iersel, Liselot, Van Der Velden, Ankie M.T., Vles, Wouter J., Van Voorthuizen, Theo, Wegdam, Johannes A., De Wilt, Johannes H.W., Koopman, Miriam, May, Anne M., Smit, Karel C., Derksen, Jeroen W.G., Beets, Geerard L.O., Belt, Eric J.Th, Berbée, Maaike, Coene, Peter Paul L.O., Van Cruijsen, Hester, Davidis, Marjan A., Dekker, Jan Willem T., Van Dodewaard-De Jong, Joyce M., Haringhuizen, Annebeth W., Helgason, Helgi H., Hendriks, Mathijs P., Hoekstra, Ronald, De Hingh, Ignace H.J.T., Ijzermans, Jan N.M., Janssen, Johan J.B., Konsten, Joop L.M., Los, Maartje, Mekenkamp, Leonie J.M., Nieboer, Peter, Peeters, Koen C.M.J., Peters, Natascha A.J.B., Pruijt, Hans J.F.M., Van Ufford-Mannesse, Patricia Quarles, Rietbroek, Ron C., Schiphorst, Anandi H.W., Van Der Velden, Arjan Schouten, Schrauwen, Ruud W.M., Sie, Mark P.S., Sommeijer, Dirkje W., Sonneveld, Dirk J.A., Stockmann, Hein B.A.C., Tent, Marleen, Terheggen, Frederiek, Tjin-A-Ton, Manuel L.R., Valkenburg-Van Iersel, Liselot, Van Der Velden, Ankie M.T., Vles, Wouter J., Van Voorthuizen, Theo, Wegdam, Johannes A., De Wilt, Johannes H.W., Koopman, Miriam, and May, Anne M.

Abstract

Regular physical activity (PA) is associated with improved overall survival (OS) in stage I-III colorectal cancer (CRC) patients. This association is less defined in patients with metastatic CRC (mCRC). We therefore conducted a study in mCRC patients participating in the Prospective Dutch Colorectal Cancer cohort. PA was assessed with the validated SQUASH questionnaire, filled-in within a maximum of 60 days after diagnosis of mCRC. PA was quantified by calculating Metabolic Equivalent Task (MET) hours per week. American College of Sports and Medicine (ACSM) PA guideline adherence, tertiles of moderate to vigorous PA (MVPA), and sport and leisure time MVPA (MVPA-SL) were assessed as well. Vital status was obtained from the municipal population registry. Cox proportional-hazards models were used to study the association between PA determinants and all-cause mortality adjusted for prognostic patient and treatment-related factors. In total, 293 mCRC patients (mean age 62.9±10.6 years, 67% male) were included in the analysis. Compared to low levels, moderate and high levels of MET-hours were significantly associated with longer OS (fully adjusted hazard ratios: 0.491, (95% CI 0.299-0.807, p value=0.005) and 0.485 (95% CI 0.303-0.778, p value=0.003), respectively), as were high levels of MVPA (0.476 (95% CI 0.278-0.816, p value=0.007)) and MVPA-SL (0.389 (95% CI 0.224-0.677, p value<0.001)), and adherence to ACSM PA guidelines compared to non-adherence (0.629 (95% CI 0.412-0.961, p value=0.032)). The present study provides evidence that higher PA levels at diagnosis of mCRC are associated with longer OS.

Published
2022

16. Physical Activity Is Associated with Improved Overall Survival among Patients with Metastatic Colorectal Cancer

Author

Epi Kanker Team B, Cancer, MS Medische Oncologie, Epidemiology & Health Economics, JC onderzoeksprogramma Kanker, Smit, Karel C, Derksen, Jeroen W G, Beets, Geerard L O, Belt, Eric J Th, Berbée, Maaike, Coene, Peter Paul L O, van Cruijsen, Hester, Davidis, Marjan A, Dekker, Jan Willem T, van Dodewaard-de Jong, Joyce M, Haringhuizen, Annebeth W, Helgason, Helgi H, Hendriks, Mathijs P, Hoekstra, Ronald, de Hingh, Ignace H J T, IJzermans, Jan N M, Janssen, Johan J B, Konsten, Joop L M, Los, Maartje, Mekenkamp, Leonie J M, Nieboer, Peter, Peeters, Koen C M J, Peters, Natascha A J B, Pruijt, Hans J F M, Quarles van Ufford-Mannesse, Patricia, Rietbroek, Ron C, Schiphorst, Anandi H W, Schouten van der Velden, Arjan, Schrauwen, Ruud W M, Sie, Mark P S, Sommeijer, Dirkje W, Sonneveld, Dirk J A, Stockmann, Hein B A C, Tent, Marleen, Terheggen, Frederiek, Tjin-A-Ton, Manuel L R, Valkenburg-van Iersel, Liselot, van der Velden, Ankie M T, Vles, Wouter J, van Voorthuizen, Theo, Wegdam, Johannes A, de Wilt, Johannes H W, Koopman, Miriam, May, Anne M, On Behalf Of The Plcrc Study Group, Epi Kanker Team B, Cancer, MS Medische Oncologie, Epidemiology & Health Economics, JC onderzoeksprogramma Kanker, Smit, Karel C, Derksen, Jeroen W G, Beets, Geerard L O, Belt, Eric J Th, Berbée, Maaike, Coene, Peter Paul L O, van Cruijsen, Hester, Davidis, Marjan A, Dekker, Jan Willem T, van Dodewaard-de Jong, Joyce M, Haringhuizen, Annebeth W, Helgason, Helgi H, Hendriks, Mathijs P, Hoekstra, Ronald, de Hingh, Ignace H J T, IJzermans, Jan N M, Janssen, Johan J B, Konsten, Joop L M, Los, Maartje, Mekenkamp, Leonie J M, Nieboer, Peter, Peeters, Koen C M J, Peters, Natascha A J B, Pruijt, Hans J F M, Quarles van Ufford-Mannesse, Patricia, Rietbroek, Ron C, Schiphorst, Anandi H W, Schouten van der Velden, Arjan, Schrauwen, Ruud W M, Sie, Mark P S, Sommeijer, Dirkje W, Sonneveld, Dirk J A, Stockmann, Hein B A C, Tent, Marleen, Terheggen, Frederiek, Tjin-A-Ton, Manuel L R, Valkenburg-van Iersel, Liselot, van der Velden, Ankie M T, Vles, Wouter J, van Voorthuizen, Theo, Wegdam, Johannes A, de Wilt, Johannes H W, Koopman, Miriam, May, Anne M, and On Behalf Of The Plcrc Study Group

Published
2022

17. Quality of Life and Survival of Metastatic Colorectal Cancer Patients Treated With Trifluridine-Tipiracil (QUALITAS)

Author

Hamers, Patricia A.H., primary, Vink, Geraldine R., additional, Elferink, Marloes A.G., additional, Stellato, Rebecca K., additional, Dijksterhuis, Willemieke P.M., additional, Punt, Cornelis J.A., additional, Koopman, Miriam, additional, May, Anne M., additional, Beerepoot, Laurens V., additional, Creemers, Geert-Jan, additional, van Cruijsen, Hester, additional, de Groot, Jan Willem B., additional, van Halteren, Henk K., additional, Helgason, Helgi H., additional, Hendriks, Mathijs P., additional, Hoekstra, Ronald, additional, van Huis-Tanja, Lieke H., additional, Kapiteijn, Ellen, additional, Los, Maartje, additional, van Meerten, Esther, additional, Peters, Natascha A.J.B., additional, Pruijt, Johannes F.M., additional, van Ufford-Mannesse, Patricia Quarles, additional, Sie, Mark P.S., additional, Sommeijer, Dirkje W., additional, Spierings, Leontine E.A.M.M., additional, Terheggen, Frederiek, additional, Tjin-A-Ton, Manuel L.R., additional, Valkenburg-van Iersel, Liselot B.J., additional, van Voorthuizen, Theo, additional, de Vos-Geelen, Judith, additional, Vulink, Annelie J.E., additional, and J van de Wouw, Agnès, additional

Published
2022
Full Text
View/download PDF

18. Internships as a Means of Training Educational Leaders: An Historical and Contextual Perspective.

Author

Hoekstra, Ronald B.

Abstract

The model for internships in school administration came from other professional fields, particularly medicine. Internship programs for master's degree candidates have generally focused on middle-management positions, such as school principal. Often such programs have been offered by local and county school districts, independently of teacher-training institutions. On the other hand, university-based internships have usually been doctoral degree programs focused on top-level administrative assignments. There is a need to reflect systematically on the concept of internships as they relate to apparent changing patterns of leadership development and training. As leadership programs change in response to the varying needs of the systems of education, the function and structure of internships also will change. Careful chronicling of that change and subsequent review of resulting modifications in internships would be helpful in establishing a foundation on which to build a more precise description of alternative internship structures, of how they work, and of what their impact might be. (Author/JG)

Published
1975

19. Trajectories of health-related quality of life and psychological distress in patients with colorectal cancer: A population-based study

Author

Qaderi, Seyed M., primary, van der Heijden, Joost A.G., additional, Verhoeven, Rob H.A., additional, de Wilt, Johannes H.W., additional, Custers, Jose A.E., additional, Beets, Geerard L., additional, Belt, Eric J.Th., additional, Berbée, Maaike, additional, Beverdam, Frederique H., additional, Blankenburgh, Ruud, additional, Coene, Peter Paul L.O., additional, de Groot, Jan Willem B., additional, de Hingh, Ignace H.J.T., additional, de Vos, Aad I., additional, Dekker, Jan Willem T., additional, Erdkamp, Frans L.G., additional, Haringhuizen, Annebeth W., additional, Helgason, Helgi H., additional, Hendriks, Mathijs P., additional, Hoekstra, Ronald, additional, Ijzermans, Jan N.M., additional, Jansen, Jan, additional, Kloppenberg, Frank W.H., additional, Los, Maartje, additional, Meijerink, Martijn R., additional, Mekenkamp, Leonie J.M., additional, Nieboer, Peter, additional, Peeters, Koen C.M.J., additional, Peters, Natascha A.J.B., additional, Polée, Marco B., additional, Pruijt, Johannes F.M., additional, van Ufford-Mannesse, Patricia Quarles, additional, Rietbroek, Ron C., additional, Schiphorst, Anandi H.W., additional, van der Velden, Arjan Schouten, additional, Schrauwen, Ruud W.M., additional, Sie, Mark P.S., additional, Simkens, Lieke, additional, Sommeijer, Dirkje W., additional, Sonneveld, Dirk J.A., additional, Spierings, Leontine E.A., additional, Stockmann, Hein B.A.C., additional, Talsma, Koen, additional, ten Tije, Albert J., additional, Terheggen, Frederiek, additional, Tjin-A-Ton, Manuel L.R., additional, Valkenburg-van Iersel, Liselot B.J., additional, van Cruijsen, Hester, additional, Velden, Ankie M.T. van der, additional, van Dodewaard-de Jong, Joyce M., additional, van Lent, Anja U.G., additional, van Voorthuizen, Theo, additional, Vermaas, Maarten, additional, Vles, Wouter J., additional, Vogelaar, Jeroen F.J., additional, and Zimmerman, David D.E., additional

Published
2021
Full Text
View/download PDF

20. The Prospective Dutch Colorectal Cancer (PLCRC) cohort: real-world data facilitating research and clinical care

Author

Derksen, Jeroen W. G., Vink, Geraldine R., Elferink, Marloes A. G., Roodhart, Jeanine M. L., Verkooijen, Helena M., van Grevenstein, Wilhelmina M. U., Siersema, Peter D., May, Anne M., Koopman, Miriam, Beets, Geerard L., Belt, Eric J. Th., Berbée, Maaike, Beverdam, Frederique H., Blankenburgh, Ruud, Coene, Peter Paul L. O., van Cruijsen, Hester, Dekker, Jan Willem T., van Dodewaard-de Jong, Joyce M., Erdkamp, Frans L. G., de Groot, Jan Willem B., Haringhuizen, Annebeth W., Helgason, Helgi H., Hendriks, Mathijs P., de Hingh, Ignace H. J. T., Hoekstra, Ronald, Ijzermans, Jan N. M., Jansen, Jan, Kloppenberg, Frank W. H., van Lent, Anja U. G., Los, Maartje, Meijerink, Martijn R., Mekenkamp, Leonie J. M., Nieboer, Peter, Peeters, Koen C. M. J., Peters, Natascha A. J. B., Polée, Marco B., Pruijt, Johannes F. M., Punt, Cornelis J. A., van Ufford-Mannesse, Patricia Quarles, Rietbroek, Ron C., Schiphorst, Anandi H. W., van der Velden, Arjan Schouten, Schrauwen, Ruud W. M., Sie, Mark P. S., Simkens, Lieke, Sommeijer, Dirkje W., Sonneveld, Dirk J. A., Spierings, Leontine E. A., Stockmann, Hein B. A. C., Talsma, Koen, Terheggen, Frederiek, ten Tije, Albert J., Tjin-A-Ton, Manuel L. R., Valkenburg-van Iersel, Liselot B. J., Veenstra, Renzo P., van der Velden, Ankie M. T., Vermaas, Maarten, Vles, Wouter J., Vogelaar, Jeroen F. J., van Voorthuizen, Theo, de Vos, Aad I., Wegdam, Johannes A., de Wilt, Johannes H. W., Zimmerman, David D. E., Surgery, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Epidemiologie, CCA - Cancer Treatment and quality of life, Radiology and nuclear medicine, Internal medicine, and VU University medical center

Subjects
Male, medicine.medical_specialty, Colorectal cancer, Epidemiology, Science, Population, MODELS, MEDLINE, Logistic regression, Representativeness heuristic, Article, 03 medical and health sciences, Tumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14], 0302 clinical medicine, Cancer epidemiology, Medical research, All institutes and research themes of the Radboud University Medical Center, SDG 3 - Good Health and Well-being, Multidisciplinary approach, COLON, medicine, Humans, 030212 general & internal medicine, Prospective Studies, Registries, education, Aged, Netherlands, Aged, 80 and over, education.field_of_study, Multidisciplinary, business.industry, Middle Aged, medicine.disease, Cancer registry, TRIALS, Outcomes research, 030220 oncology & carcinogenesis, Family medicine, Cohort, Medicine, Female, business, Colorectal Neoplasms
Abstract

Real-world data (RWD) sources are important to advance clinical oncology research and evaluate treatments in daily practice. Since 2013, the Prospective Dutch Colorectal Cancer (PLCRC) cohort, linked to the Netherlands Cancer Registry, serves as an infrastructure for scientific research collecting additional patient-reported outcomes (PRO) and biospecimens. Here we report on cohort developments and investigate to what extent PLCRC reflects the “real-world”. Clinical and demographic characteristics of PLCRC participants were compared with the general Dutch CRC population (n = 74,692, Dutch-ref). To study representativeness, standardized differences between PLCRC and Dutch-ref were calculated, and logistic regression models were evaluated on their ability to distinguish cohort participants from the Dutch-ref (AU-ROC 0.5 = preferred, implying participation independent of patient characteristics). Stratified analyses by stage and time-period (2013–2016 and 2017–Aug 2019) were performed to study the evolution towards RWD. In August 2019, 5744 patients were enrolled. Enrollment increased steeply, from 129 participants (1 hospital) in 2013 to 2136 (50 of 75 Dutch hospitals) in 2018. Low AU-ROC (0.65, 95% CI: 0.64–0.65) indicates limited ability to distinguish cohort participants from the Dutch-ref. Characteristics that remained imbalanced in the period 2017–Aug’19 compared with the Dutch-ref were age (65.0 years in PLCRC, 69.3 in the Dutch-ref) and tumor stage (40% stage-III in PLCRC, 30% in the Dutch-ref). PLCRC approaches to represent the Dutch CRC population and will ultimately meet the current demand for high-quality RWD. Efforts are ongoing to improve multidisciplinary recruitment which will further enhance PLCRC’s representativeness and its contribution to a learning healthcare system.

Published
2021
Full Text
View/download PDF

21. Survival of patients with deficient mismatch repair metastatic colorectal cancer in the pre-immunotherapy era

Author

Verpleegafdeling Medische Oncologie, Onderzoek Medische Oncologie, Cancer, Epidemiology & Health Economics, JC onderzoeksprogramma Kanker, MS Medische Oncologie, Wensink, G Emerens, Elferink, Marloes A G, May, Anne M, Mol, Linda, Hamers, Patricia A H, Bakker, Sandra D, Creemers, Geert-Jan, de Groot, Jan Willem B, de Klerk, Gerty J, Haberkorn, Brigitte C M, Haringhuizen, Annebeth W, Hoekstra, Ronald, Hunting, J Cornelis B, Kerver, Emile D, Mathijssen-van Stein, Danielle, Polée, Marco B, Pruijt, Johannes F M, Quarles van Ufford-Mannesse, Patricia, Radema, Sandra, Rietbroek, Ronald C, Simkens, Lieke H J, Tanis, Bea C, Ten Bokkel Huinink, Daan, Tjin-A-Ton, Manuel L R, Tromp-van Driel, Cathrien S, Troost, Monique M, van de Wouw, Agnes J, van den Berkmortel, Franchette W P J, van der Pas, Anke J M, van der Velden, Ankie M T, van Dijk, Marjan A, van Dodewaard-de Jong, Joyce M, van Druten, Edith B, van Voorthuizen, Theo, Jan Veldhuis, Gerrit, Verheul, Henk M W, Vestjens, Hanneke J H M J, Vincent, Jeroen, Kranenburg, Onno W, Punt, Cornelis J A, Vink, Geraldine R, Roodhart, Jeanine M L, Koopman, Miriam, Verpleegafdeling Medische Oncologie, Onderzoek Medische Oncologie, Cancer, Epidemiology & Health Economics, JC onderzoeksprogramma Kanker, MS Medische Oncologie, Wensink, G Emerens, Elferink, Marloes A G, May, Anne M, Mol, Linda, Hamers, Patricia A H, Bakker, Sandra D, Creemers, Geert-Jan, de Groot, Jan Willem B, de Klerk, Gerty J, Haberkorn, Brigitte C M, Haringhuizen, Annebeth W, Hoekstra, Ronald, Hunting, J Cornelis B, Kerver, Emile D, Mathijssen-van Stein, Danielle, Polée, Marco B, Pruijt, Johannes F M, Quarles van Ufford-Mannesse, Patricia, Radema, Sandra, Rietbroek, Ronald C, Simkens, Lieke H J, Tanis, Bea C, Ten Bokkel Huinink, Daan, Tjin-A-Ton, Manuel L R, Tromp-van Driel, Cathrien S, Troost, Monique M, van de Wouw, Agnes J, van den Berkmortel, Franchette W P J, van der Pas, Anke J M, van der Velden, Ankie M T, van Dijk, Marjan A, van Dodewaard-de Jong, Joyce M, van Druten, Edith B, van Voorthuizen, Theo, Jan Veldhuis, Gerrit, Verheul, Henk M W, Vestjens, Hanneke J H M J, Vincent, Jeroen, Kranenburg, Onno W, Punt, Cornelis J A, Vink, Geraldine R, Roodhart, Jeanine M L, and Koopman, Miriam

Published
2021

22. Work Ability in Patients With Stage I to IV Colon Cancer: Results of the Dutch Prospective Colorectal Cancer Cohort

Author

Franken, Mira D., Vink, Geraldine, van Grevenstein, Wilhelmina M.U., Verkooijen, Helena M., Punt, Cornelis J.A., Koopman, Miriam, May, Anne M., Beets, Geerard L., Belt, Eric J.Th., Berbée, Maaike, Beverdam, Frederique H., Blankenburgh, Ruud, Coene, Peter Paul L.O., de Groot, Jan Willem B., de Hingh, Ignace H.J.T., de Vos, Aad I., de Wilt, Johannes H.W., Dekker, Jan Willem T., Erdkamp, Frans L.G., Haringhuizen, Annebeth W., Helgason, Helgi H., Hendriks, Mathijs P., Hoekstra, Ronald, Ijzermans, Jan N.M., Jansen, Jan, Kloppenberg, Frank W.H., Los, Maartje, Meijerink, Martijn R., Mekenkamp, Leonie J.M., Nieboer, Peter, Peeters, Koen C.M.J., Peters, Natascha A.J.B., Pruijt, Johannes F.M., van Ufford-Mannesse, Patricia Quarles, Rietbroek, Ron C., Schiphorst, Anandi H.W., Sie, Mark P.S., Simkens, Lieke H.J., Sommeijer, Dirkje W., Spierings, Leontine E.A., Stockmann, Hein B.A.C., ten Tije, Albert J., Terheggen, Frederiek, Tjin-A-Ton, Manuel L.R., Valkenburg-van Iersel, Liselot B.J., van Cruijsen, Hester, van der Velden, Ankie M.T., van Dodewaard-de Jong, Joyce M., van Lent, Anja U.G., Voorthuizen, Theo van, Vermaas, Maarten, Vles, Wouter J., Vogelaar, Jeroen F.J., and Zimmerman, David D.E.

Published
2023
Full Text
View/download PDF

23. The Impact of Erythropoietin on Short- and Long-Term Kidney-Related Outcomes in Neonates of Extremely Low Gestational Age. Results of a Multicenter, Double-Blind, Placebo-Controlled Randomized Clinical Trial

Author

Askenazi, David J., primary, Heagerty, Patrick J., additional, Schmicker, Robert H., additional, Brophy, Patrick, additional, Juul, Sandra E., additional, Goldstein, Stuart L., additional, Hingorani, Sangeeta, additional, Comstock, Bryan A., additional, Wadhawan, Rajan, additional, Mayock, Dennis E., additional, Courtney, Sherry E., additional, Robinson, Tonya, additional, Ahmad, Kaashif A., additional, Bendel-Stenzel, Ellen, additional, Baserga, Mariana, additional, LaGamma, Edmund F., additional, Downey, L. Corbin, additional, Rao, Raghavendra, additional, Fahim, Nancy, additional, Lampland, Andrea, additional, Frantz, Ivan D., additional, Khan, Janine Y., additional, Weiss, Michael, additional, Gilmore, Maureen M., additional, Ohls, Robin, additional, Srinivasan, Nishant, additional, Perez, Jorge E., additional, McKay, Victor, additional, Vu, Phuong T., additional, Thomas, Billy, additional, Elhassan, Nahed, additional, Mulkey, Sarah, additional, Dydynski, Philip, additional, Vijayamadhavan, Vivek K., additional, Mulrooney, Neil, additional, Yoder, Bradley, additional, Kase, Jordan S., additional, Check, Jennifer, additional, Gogcu, Semsa, additional, Osterholm, Erin, additional, Ramel, Sara, additional, Bendel, Catherine, additional, Gale, Cheryl, additional, George, Thomas, additional, Georgieff, Michael, additional, Gisslen, Tate, additional, Guiang, Sixto, additional, Hall, Anne, additional, Johnson, Dana, additional, Pfister, Katie, additional, Podgorski, Heather, additional, Roberts, Kari, additional, Stepka, Erin, additional, Engel, Melissa, additional, Kamrath, Heidi, additional, Scheurer, Johannah, additional, Hanson, Angela, additional, Satrom, Katherine, additional, Pfister, Susan, additional, Simones, Ann, additional, Plummer, Erin, additional, Zorn, Elizabeth, additional, Martin, Camilia R., additional, O'Reilly, Deirdre, additional, Porta, Nicolas, additional, Bazacliu, Catalina, additional, Williams, Jonathan, additional, Rajderkar, Dhanashree, additional, Northington, Frances, additional, Valdez, Raul Chavez, additional, Beauman, Sandra, additional, Saurabhkumar, Patel, additional, Diaz-Barbosa, Magaly, additional, Serize, Arturo, additional, Jordan, Jorge, additional, Ott, Debbie, additional, Mora, Ariana Franco, additional, Hedrick, Pamela, additional, Flynn, Vicki, additional, Silvia, Amy, additional, Clopp, Bailey, additional, Feltner, John B., additional, Esposito, Isabella, additional, Hauge, Stephanie, additional, Nikirk, Samantha, additional, Purnell, Andrea, additional, Loy, Emilie, additional, Sikes, Natalie, additional, Mason, Melanie, additional, McConnell, Jana, additional, Brown, Tiffany, additional, Harrison, Henry, additional, Pearson, Denise, additional, Drake, Tammy, additional, Wright, Jocelyn, additional, Walden, Debra, additional, Guy, Annette, additional, Nason, Jennifer, additional, Talbot, Morgan, additional, Lee, Kristen, additional, Penny, Sarah, additional, Boles, Terri, additional, Drummond, Melanie, additional, Kohlleppel, Katy, additional, Kathen, Charmaine, additional, Kaletka, Brian, additional, Gonzales, Shania, additional, Worwa, Cathy, additional, Fisher, Molly, additional, Richter, Tyler, additional, Ginder, Alexander, additional, Reich, Brixen, additional, Rau, Carrie, additional, Loertscher, Manndi, additional, Bledsoe, Laura, additional, McGrath, Kandace, additional, Lewis, Kimberlee Weaver, additional, Burnett, Jill, additional, Schaefer, Susan, additional, Bird, Karie, additional, Giblin, Clare, additional, Daly, Rita, additional, Lanier, Kristi, additional, Warden, Kelly, additional, Wassenaar, Jenna, additional, Ericksen, Jensina, additional, Davern, Bridget, additional, Osborne, Mary Pat, additional, Gregorich, Brittany, additional, Talele, Neha, additional, Obregon, Evelyn, additional, Ziyeh, Tiglath, additional, Clarke, Molly, additional, Wegner, Rachel E., additional, Patel, Palak, additional, Schau, Molly, additional, Russow, Annamarie, additional, Curry, Kelly, additional, Sinnamon, Susan, additional, Barnhart, Lisa, additional, Parkinson, Charlamaine, additional, Hanson, Mary, additional, Kuan, Elizabeth, additional, Lacy, Conra Backstrom, additional, Galvis, Edshelee M., additional, Bombino, Susana, additional, Martinez, Denise, additional, Bell, Suzi, additional, Long, Corrie, additional, Longa, Cathy, additional, Westerveld, Michael, additional, McConkey, Stacy, additional, Hay, Anne, additional, Natarajan, Niranjana, additional, Gaudette, Shari, additional, Cobb, Sarah, additional, Sharp, Gregory, additional, Schumacher, Elizabeth, additional, Schuschke, Leslie, additional, Frey, Charlotte, additional, Fierro, Mario, additional, Gilmore, Lois, additional, Lundequam, Pamela, additional, Hoekstra, Ronald, additional, Ketko, Anastasia, additional, Perdue, Nina, additional, Cunningham, Sean, additional, Stout, Kelly, additional, Hall, Becky, additional, Morshedzadeh, Galina, additional, Ostrander, Betsy, additional, Winter, Sarah, additional, Cox, Lauren, additional, Rainaldi, Matthew A., additional, Hensley, Sarah, additional, Morris, Melissa, additional, Roberts, Dia, additional, Tuttle, Melissa, additional, Boys, Christopher, additional, Hultgren, Solveig, additional, Pierpont, Elizabeth I., additional, George, Tom, additional, King, Kelly E., additional, Bataglia, Katherine, additional, Neis, Cathy, additional, Bergeron, Mark, additional, Miller, Cristina, additional, Accomando, Cara, additional, Gavin, Jennifer Anne, additional, Maczek, Elizabeth, additional, Marakovitz, Susan, additional, Knorr, Aimee, additional, Smith, Vincent C., additional, Stewart, Jane E., additional, Weissbourd, Marie, additional, deRegnier, Raye-Ann, additional, Matoba, Nana, additional, Heaton, Shelly C., additional, Cascio, Erika M., additional, Brady, Janet, additional, Ghosh, Suman, additional, Ditto, Jessica, additional, Leppert, Mary, additional, Lowe, Jean, additional, Fuller, Janell, additional, DuPont, Tara, additional, Kloska, Pamela, additional, Patel, Saurabh, additional, Carbonell, Lauren, additional, Patino-Fernandez, Anna Maria, additional, de Lerma, Carmen, additional, McDonough, Kelly, additional, De Cortada, Maiana, additional, Chavis, Lacy, additional, Shannon, Jane, additional, Konodi, Mark A., additional, Nefcy, Christopher, additional, Kuban, Karl C.K., additional, Lowe, Jean R., additional, O'Shea, T. Michael, additional, Dighe, Manjiri, additional, Richards, Todd, additional, Shaw, Dennis W.W., additional, Studholme, Colin, additional, Traudt, Christopher M., additional, Ballard, Roberta, additional, Hartman, Adam, additional, Janis, Scott, additional, Ohls, T. Robin, additional, O'Shea, Michael, additional, Guillet, Ronnie, additional, Ball, M. Bethany, additional, Glass, Hannah, additional, Saville, Ben, additional, and Schreiber, Michael, additional

Published
2021
Full Text
View/download PDF

24. Circulating tumor DNA guided adjuvant chemotherapy in stage II colon cancer (MEDOCC-CrEATE): Study protocol for a trial within a cohort study

Author

Schraa, S. J., Van Rooijen, K. L., Van Der Kruijssen, D. E.W., Rubio Alarcón, C., Phallen, J., Sausen, M., Simmons, J., Coupé, V. M.H., Van Grevenstein, W. M.U., Elias, S., Verkooijen, H. M., Laclé, M. M., Bosch, L. J.W., Van Den Broek, D., Meijer, G. A., Velculescu, V. E., Fijneman, R. J.A., Vink, G. R., Koopman, M., Dunker, Mich S., Lutke Holzik, Martijn F., Hoekstra, Ronald, Sommeijer, Dirkje W., Van Der Bilt, Jarmila D.W., Consten, Esther C.J., Cirkel, Geert A., Burghgraef, Thijs A., Van Der Schans, Emma M., Nieboer, Peter, Rietbroek, Ron C., Dekker, Jan Willem T., Verschoor, Arjan J., Talsma, Koen A.K., Brosens, Rebecca P.M., Helgason, Helgi H., Marinelli, Andreas W.K.S., De Hingh, Ignace H.J.T., Oldenhuis, Corina N., Jansen, Jan, Van Halteren, Henk K., Stockmann, Hein B.A.C., Beeker, Aart, Bosscha, Koop, Pruijt, Hans F.M., Spierings, Leontine E.A.M.M., Valkenburg-Van Iersel, Liselot B.J., Vles, Wouter J., De Jongh, Felix E., Van Cruijsen, Hester, Heikens, Joost T., Zimmerman, David D.E., Van Alphen, Robert J., Schiphorst, Anandi H.W., Van Leeuwen-Snoeks, Lobke L., Vogelaar, Jeroen F.J., Peters, Natascha A.J.B., Epidemiology and Data Science, APH - Methodology, CCA - Cancer Treatment and quality of life, Pathology, Internal medicine, Orthopedic Surgery and Sports Medicine, VU University medical center, Surgery, ​Robotics and image-guided minimally-invasive surgery (ROBOTICS), RS: NUTRIM - R3 - Respiratory & Age-related Health, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, MUMC+: MA Medische Oncologie (9), Medical Biology, Nephrology, and Oncology

Subjects
0301 basic medicine, Oncology, Male, Cancer Research, Neoplasm, Residual, Colorectal cancer, Cost-Benefit Analysis, COLORECTAL-CANCER, Circulating Tumor DNA, Study Protocol, 0302 clinical medicine, RESIDUAL DISEASE, Antineoplastic Combined Chemotherapy Protocols, Clinical endpoint, Prospective Studies, Colectomy, Netherlands, Randomized Controlled Trials as Topic, RISK, education.field_of_study, RANDOMIZED CONTROLLED-TRIAL, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Colon cancer, Oxaliplatin, Chemotherapy, Adjuvant, CELL-FREE DNA, 030220 oncology & carcinogenesis, Colonic Neoplasms, Practice Guidelines as Topic, SURVIVAL, Female, medicine.drug, Cohort study, Adult, medicine.medical_specialty, Population, TwiCs, lcsh:RC254-282, Disease-Free Survival, LEUCOVORIN, Capecitabine, 03 medical and health sciences, Internal medicine, Genetics, medicine, Biomarkers, Tumor, Humans, RECURRENCE, education, Neoplasm Staging, Intention-to-treat analysis, business.industry, Liquid Biopsy, ctDNA, Patient Acceptance of Health Care, medicine.disease, Minimal residual disease, FLUOROURACIL, Adjuvant chemotherapy, 030104 developmental biology, Quality of Life, Neoplasm Recurrence, Local, business, Follow-Up Studies
Abstract

Background Accurate detection of patients with minimal residual disease (MRD) after surgery for stage II colon cancer (CC) remains an urgent unmet clinical need to improve selection of patients who might benefit form adjuvant chemotherapy (ACT). Presence of circulating tumor DNA (ctDNA) is indicative for MRD and has high predictive value for recurrent disease. The MEDOCC-CrEATE trial investigates how many stage II CC patients with detectable ctDNA after surgery will accept ACT and whether ACT reduces the risk of recurrence in these patients. Methods/design MEDOCC-CrEATE follows the ‘trial within cohorts’ (TwiCs) design. Patients with colorectal cancer (CRC) are included in the Prospective Dutch ColoRectal Cancer cohort (PLCRC) and give informed consent for collection of clinical data, tissue and blood samples, and consent for future randomization. MEDOCC-CrEATE is a subcohort within PLCRC consisting of 1320 stage II CC patients without indication for ACT according to current guidelines, who are randomized 1:1 into an experimental and a control arm. In the experimental arm, post-surgery blood samples and tissue are analyzed for tissue-informed detection of plasma ctDNA, using the PGDx elio™ platform. Patients with detectable ctDNA will be offered ACT consisting of 8 cycles of capecitabine plus oxaliplatin while patients without detectable ctDNA and patients in the control group will standard follow-up according to guideline. The primary endpoint is the proportion of patients receiving ACT when ctDNA is detectable after resection. The main secondary outcome is 2-year recurrence rate (RR), but also includes 5-year RR, disease free survival, overall survival, time to recurrence, quality of life and cost-effectiveness. Data will be analyzed by intention to treat. Discussion The MEDOCC-CrEATE trial will provide insight into the willingness of stage II CC patients to be treated with ACT guided by ctDNA biomarker testing and whether ACT will prevent recurrences in a high-risk population. Use of the TwiCs design provides the opportunity to randomize patients before ctDNA measurement, avoiding ethical dilemmas of ctDNA status disclosure in the control group. Trial registration Netherlands Trial Register: NL6281/NTR6455. Registered 18 May 2017, https://www.trialregister.nl/trial/6281

Published
2020
Full Text
View/download PDF

26. Survival of patients with deficient mismatch repair metastatic colorectal cancer in the pre-immunotherapy era

Author

Wensink, G. Emerens, primary, Elferink, Marloes A. G., additional, May, Anne M., additional, Mol, Linda, additional, Hamers, Patricia A. H., additional, Bakker, Sandra D., additional, Creemers, Geert-Jan, additional, de Groot, Jan Willem B., additional, de Klerk, Gerty J., additional, Haberkorn, Brigitte C. M., additional, Haringhuizen, Annebeth W., additional, Hoekstra, Ronald, additional, Hunting, J. Cornelis B., additional, Kerver, Emile D., additional, Mathijssen-van Stein, Danielle, additional, Polée, Marco B., additional, Pruijt, Johannes F. M., additional, Quarles van Ufford-Mannesse, Patricia, additional, Radema, Sandra, additional, Rietbroek, Ronald C., additional, Simkens, Lieke H. J., additional, Tanis, Bea C., additional, ten Bokkel Huinink, Daan, additional, Tjin-A-Ton, Manuel L. R., additional, Tromp-van Driel, Cathrien S., additional, Troost, Monique M., additional, van de Wouw, Agnes J., additional, van den Berkmortel, Franchette W. P. J., additional, van der Pas, Anke J. M., additional, van der Velden, Ankie M. T., additional, van Dijk, Marjan A., additional, van Dodewaard-de Jong, Joyce M., additional, van Druten, Edith B., additional, van Voorthuizen, Theo, additional, Jan Veldhuis, Gerrit, additional, Verheul, Henk M. W., additional, Vestjens, Hanneke J. H. M. J., additional, Vincent, Jeroen, additional, Kranenburg, Onno W., additional, Punt, Cornelis J. A., additional, Vink, Geraldine R., additional, Roodhart, Jeanine M. L., additional, and Koopman, Miriam, additional

Published
2020
Full Text
View/download PDF

30. Improved neonatal survival following multiple doses of bovine surfactant in very premature neonates at risk for respiratory distress syndrome

Author

Hoekstra, Ronald E., Jackson, J. Craig, Myers, Thomas F., Frantz, Ivan D., III, Stern, Mitchell E., Powers, William F., Maurer, Michael, Raye, John R., Carrier, Steven T., Gunkel, J. Harry, and Gold, Alan J.

Subjects
Respiratory distress syndrome -- Prevention, Lung surfactant, Synthetic -- Evaluation, Lung surfactant, Synthetic -- Dosage and administration, Respiratory distress syndrome -- Drug therapy, Infants (Premature) -- Diseases
Abstract

Infants born prematurely have an increased risk of respiratory distress syndrome, a lung disorder, because the lungs are still immature and do not produce adequate quantities of a substance called surfactant. This condition can be fatal. Studies have shown that a natural surfactant derived from other species given once at birth to these infants can reduce the severity of respiratory distress syndrome, but survival rates have not been shown to increase. This study examined whether giving multiple doses of a natural surfactant derived from cows (bovine surfactant) to these infants could increase their chances of surviving respiratory distress syndrome. Infants born at 23 to 29 weeks gestation weighing between 600 and 1,250 grams (1.3 to 2.8 pounds) were included in the study. A total of 430 infants participated, with 210 assigned to the treatment group and 220 to the control group. The treatment group received the surfactant at birth and again when needed (delivered into the trachea, or windpipe), while the control group received a dose of air, which functioned as a placebo. Results showed that in the first 28 days after birth, 1.9 percent of the treated and 15.6 percent of the untreated infants died from respiratory problems, a significant difference. Respiratory distress syndrome developed in 28 percent of the treated and in 56.9 percent of the control infants. The treated infants also had lower rates of developing pulmonary interstitial emphysema, at 23.3 percent versus 36.9 percent for the control group. These results indicate that multiple treatments with a natural surfactant at birth and again when needed can reduce the rates of illness and death from respiratory problems in infants born prematurely. (Consumer Summary produced by Reliance Medical Information, Inc.)

Published
1991

31. Multicenter trial of single-dose modified bovine surfactant extract (Survanta) for prevention of respiratory distress syndrome

Author

Soll, Roger F., Hoekstra, Ronald E., Fangman, John J., Corbet, Anthony J., Adams, James M., James, L. Stanley, Schulze, Karl, Oh, William, Roberts, Jesse D., Jr., Dorst, John P., Kramer, Sandra S., Gold, A. Jack, Zola, Elizabeth M., Horbar, Jeffrey D., McAuliffe, Timothy L., and Lucey, Jerold F.

Subjects
Survanta (Medication) -- Evaluation, Respiratory distress syndrome -- Drug therapy, Respiratory distress syndrome -- Prevention, Pulmonary surfactant -- Health aspects
Abstract

Respiratory distress syndrome (RDS) is a common breathing complication in premature and low-birth-weight infants. It is caused by a deficiency in surfactant, a protein which makes the lungs pliable. When the lungs are inflexible and cannot expand properly, this results in labored breathing and decreased oxygen intake. In an effort to prevent RDS, a natural surfactant can be given to infants at birth. The results of a multicenter trial of single-dose modified bovine surfactant Survanta, a surfactant derived from cows, are reported. Of the 160 low-birth-weight infants (1.7 to 2.8 pounds, or 750 to 1,250 grams) born between 24 and 30 weeks of pregnancy, 79 were treated with Survanta (100 milligrams per kilogram), while 81 were given air without surfactant. All the infants were treated within 37 minutes of birth. The study evaluations, which included chest X-rays, blood gases, inspired oxygen and airway pressure, were assessed over the next 72 hours. The infants receiving Survanta had less severe RDS assessed by chest X-ray findings and improved inspired oxygen than infants receiving no therapy. There was no major difference in the incidence of the most common complications of prematurity, namely necrotizing enterocolitis (tissue death in the intestinal tract), bronchopulmonary dysplasia (development of abnormal lung tissue), pneumothorax (leakage of air from the lungs into the thoracic cavity), intraventricular hemorrhage (bleeding in the spaces of the brain), sepsis (infection) and a patent ductus arteriosus (the maintenance of a connection between the aorta and the pulmonary artery that normally closes after birth). Treated infants had a lower incidence of pneumothorax and an increased incidence of necrotizing enterocolitis. The incidence of all other complications of prematurity were same in the treated and nontreated groups. Survanta therapy improved the inspired oxygen fraction and increased the number of survivors without bronchopulmonary dysplasia in a small subgroup of infants who weighed less than 2.2 pounds (1 kilogram). Although Survanta did not reduce the incidence of RDS complications, it was useful in decreasing the severity of chest X-ray findings and improved oxygenation in the first 72 hours of life. Infants of very low birth weights may benefit the most from Survanta therapy. (Consumer Summary produced by Reliance Medical Information, Inc.)

Published
1990

33. Survival of patients with deficient mismatch repair metastatic colorectal cancer in the pre-immunotherapy era.

Author

Wensink, G. Emerens, Elferink, Marloes A. G., May, Anne M., Mol, Linda, Hamers, Patricia A. H., Bakker, Sandra D., Creemers, Geert-Jan, de Groot, Jan Willem B., de Klerk, Gerty J., Haberkorn, Brigitte C. M., Haringhuizen, Annebeth W., Hoekstra, Ronald, Hunting, J. Cornelis B., Kerver, Emile D., Mathijssen-van Stein, Danielle, Polée, Marco B., Pruijt, Johannes F. M., Quarles van Ufford-Mannesse, Patricia, Radema, Sandra, and Rietbroek, Ronald C.

Abstract

Background: Metastatic colorectal cancer patients with deficient mismatch repair (dMMR mCRC) benefit from immunotherapy. Interpretation of the single-arm immunotherapy trials is complicated by insignificant survival data during systemic non-immunotherapy. We present survival data on a large, comprehensive cohort of dMMR mCRC patients, treated with or without systemic non-immunotherapy.Methods: Two hundred and eighty-one dMMR mCRC patients (n = 54 from three prospective Phase 3 CAIRO trials; n = 227 from the Netherlands Cancer Registry). Overall survival was analysed from diagnosis of mCRC (OS), from initiation of first-line (OS1) and second-line (OS2) systemic treatment. Cox regression analysis examined prognostic factors. As comparison for OS 2746 MMR proficient mCRC patients were identified.Results: Of 281 dMMR patients, 62% received first-line and 26% second-line treatment. Median OS was 16.0 months (13.8-19.6) with antitumour therapy and 2.5 months (1.8-3.5) in untreated patients. OS1 was 12.8 months (10.7-15.2) and OS2 6.2 months (5.4-8.9) in treated dMMR patients. Treated dMMR patients had a 7.6-month shorter median OS than pMMR patients.Conclusion: Available data from immunotherapy trials lack a control arm with standard systemic treatment. Given the poor outcome compared to the immunotherapy results, our data strongly suggest a survival benefit of immunotherapy in dMMR mCRC patients. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

34. Effects of exogenous surfactant therapy on dynamic compliance during mechanic breathing in preterm infants with hyaline membrane disease

Author

Couser, Robert J., Ferrara, T. Bruce, Ebert, Jerry, Hoekstra, Ronald E., and Fangman, John J.

Subjects
Pulmonary surfactant -- Health aspects, Pediatric respiratory diseases -- Research, Hyaline membrane disease -- Care and treatment, Health
Abstract

Surfactant is a type of lipoprotein that allows the exchange of gases in the lungs and contributes to the elasticity of the pulmonary tissue by reducing the surface tension of pulmonary fluids. Hyaline membrane disease is a serious lung condition of premature newborns characterized by inelastic lungs and very rapid respirations. Infants with hyaline membrane disease are deficient in this lipoprotein and either die within a few days of birth, or recover with no aftereffects. These babies often require mechanical ventilation. In animal studies, surfactant replacement therapy has been shown to improve lung compliance and gas exchange. There is limited data on humans concerning the use of surfactant. In this study, 94 preterm infants, weighing between 1 lb 5 oz and 2 lbs 12 oz. (600 and 1,250 grams), who were dependent on mechanical respiration received either exogenous surfactant or air therapy in the delivery room and three times afterward during the first 48 hours of life. Pulmonary mechanics assessment was performed. At 24 hours of age, there was a 50 percent greater dynamic compliance in the surfactant group, than in the group receiving air. At seven days of age the difference between the two groups was 94 percent greater dynamic compliance for the surfactant group. Oxygenation was sufficiently greater in the surfactant group during the first three days of life. The findings indicate that exogenous surfactant therapy in preterm infants with hyaline membrane disease can be helpful in improving pulmonary mechanics (dynamic compliance) and gas exchange during mechanical respiration. (Consumer Summary produced by Reliance Medical Information, Inc.)

Published
1990

36. Before Their Time

Author

TAYLOR, DANIEL and HOEKSTRA, RONALD

Subjects
Infants (Premature) -- Behavior, Premature birth -- Religious aspects
Abstract

Lessons in living form those born too soon Lamarre Foster was a premie-born at twenty-two weeks and weighing twenty ounces. Delivered on a Friday, there was real doubt Lamarre would […]

Published
2001

44. Changing outcome of extremely premature infants (less than 26 weeks gestation and 750 grams): survival and follow-up at a tertiary center

Author

Ferrara, T. Bruce, Hoekstra, Ronald E., Gaziano, Emanuel, Knox, G.Eric, Couser, Robert J., and Fangman, John J.

Subjects
Infants (Premature) -- Care and treatment, Health
Abstract

The prognosis for premature infants has improved substantially, but may not apply to very premature infants born before 26 weeks gestation who weigh less than 750 grams (1.65 lbs). Treatment of very premature infants is debatable because the survival rates have not been established. To determine survival rates the authors evaluated 175 very premature infants admitted to the neonatal intensive care unit from 1981 to 1987. Ninety-one percent of these infants were delivered in the hospital, and 73 infants survived. In 1981-1982 survival increased from 21 percent to greater than 50 percent in 1986-1987. Most of the deaths occurred within 48 hours after birth; death rarely occurred after 28 days of life. When these infants were followed-up half were normal, 27 had mild to moderate abnormalities and 23 percent were severely impaired. Improved survival did not increase the incidence of impairment. Infants previously considered nonviable are offered better chances of survival with new neonatal technology.

Published
1989

45. Phase I and Pharmacologic Study of PKI166, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients with Advanced Solid Malignancies

Author

Hoekstra, Ronald, primary, Dumez, Herlinde, additional, Eskens, Ferry A.L.M., additional, van der Gaast, Ate, additional, Planting, Andre S.T., additional, de Heus, Gerda, additional, Sizer, Kurt C., additional, Ravera, Christina, additional, Vaidyanathan, Sujata, additional, Bucana, Corazon, additional, Fidler, Isaiah J., additional, van Oosterom, Allan T., additional, and Verweij, Jaap, additional

Published
2005
Full Text
View/download PDF

46. Survival and long-term neurodevelopmental outcome of extremely premature infants born at 23-26 weeks' gestational age at a tertiary center

Author

Hoekstra, Ronald E., Ferrara, T. Bruce, Couser, Robert J., Payne, Nathaniel R., and Connett, John E.

Abstract

Objective. Long-term outcome, including school-age function, has been infrequently reported in infants born at ages as young as 23-26 weeks&apos; gestation. The objective of this study is to report outcome on a large cohort of these infants to understand better the risks and factors that affect survival and long-term prognosis. Methods. Records from 1036 infants who were born between January 1, 1986, and December 31, 2000, were analyzed retrospectively by logistic regression to correlate multiple factors with both survival and long-term outcome. A total of 675 surviving infants were analyzed at a mean age of 47.5 months for developmental outcome. A subset of 147 surviving infants who were born before 1991 were followed through school-age years using the University of Vermont Achenbach Child Behavioral Checklist and Teachers Report Form. Longitudinal follow-up was performed comparing 1-year outcome with school-age performance. Results. Gestational age and recent year of birth correlated highly with survival. Maternal nonwhite race, female sex, inborn status, surfactant therapy, single gestation, and secondary sepsis also correlated positively with survival. Normal cranial ultrasound results, absence of chronic lung disease, female sex, cesarean delivery, and increased birth weight correlated favorably with long-term outcome. Infants who were born at 23 weeks were more likely to have severe impairments compared with those who were born at 24-26 weeks. Early follow-up identified most subsequent physical impairments but correlated poorly with school-age function. Conclusions. Survival continues to improve for infants who are born at extremely early gestational ages, but long-term developmental concerns continue to be prevalent. Early outcomes do not reliably predict school-age performance. Strategies that reduce severe intraventricular hemorrhage and chronic lung disease will likely yield the best chances to improve long-term outlook. Pediatrics 2004;113:e1-e6. URL: http://www.pediatrics. org/cgi/content/full/113/1/e1; prematurity, outcome, neurodevelopment, survival, follow-up.

Published
2004

Catalog

Books, media, physical & digital resources
See catalog results